The discovery of (R)-2-(sec-butylamino)-N-(2-methyl-5-(methylcarbamoyl)phenyl) thiazole-5-carboxamide (BMS-640994)—A potent and efficacious p38α MAP kinase inhibitor
作者:John Hynes、Hong Wu、Sidney Pitt、Ding Ren Shen、Rosemary Zhang、Gary L. Schieven、Kathleen M. Gillooly、David J. Shuster、Tracy L. Taylor、XiaoXia Yang、Kim W. McIntyre、Murray McKinnon、Hongjian Zhang、Punit H. Marathe、Arthur M. Doweyko、Kevin Kish、Susan E. Kiefer、John S. Sack、John A. Newitt、Joel C. Barrish、John Dodd、Katerina Leftheris
DOI:10.1016/j.bmcl.2008.02.031
日期:2008.3
A novel structural class of p38 alpha MAP kinase inhibitors has been identified via iterative SAR studies of a focused deck screen hit. Optimization of the lead series generated 6e, BMS-640994, a potent and selective p38 alpha inhibitor that is orally efficacious in rodent models of acute and chronic inflammation. (C) 2008 Elsevier Ltd. All rights reserved.